Other
Galapagos
is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases... Read moreGalapagos
is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases... Read moreNews
Conference Presentation
Feb 25, 2025
Marketscreener
Galapagos : Galapagos to Present at Upcoming Investor Conferences
Partnership
Feb 10, 2025
EIN Presswire
NecstGen Partners with Galapagos to Advance Decentralised CAR-T Cell Manufacturing in Europe
investment
May 29, 2024
https://www.adaptimmune.com/investors-and-media/news-center/press-releases/detail/269/adaptimmune-and-galapagos-sign-clinical-collaboration
Galapagos NV has invested $100M in Adaptimmune Therapeutics PLC
Galapagos Competitors
1
2
3
4
5
6
7
8
9
10